GS
TDOC icon

GTS Securities’s Teladoc Health TDOC Stock Holding History

GTS Securities’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-32,078
Closed -$265K – 4433
2024
Q2 		$314K Sell
32,078
-56,591
-64% -$690K ﹤0.01% 3082
2024
Q1 		$1.34M Sell
88,669
-26,117
-23% -$474K ﹤0.01% 1764
2023
Q4 		$2.47M Buy
114,786
+5,222
+5% +$96.3K ﹤0.01% 1505
2023
Q3 		$2.04M Buy
109,564
+24,935
+29% +$582K ﹤0.01% 1499
2023
Q2 		$2.14M Buy
+84,629
New +$2.13M 0.07% 256

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GTS Securities's TDOC Position: Q3 2024 in Review

GTS Securities sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 32,078 shares — an estimated $265K sold.

GTS Securities first reported a position in TDOC in Q2 2023 and held it in 5 quarters. The position peaked at $2.47M in Q4 2023. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • GTS Securities reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 32,078 Teladoc Health shares in Q3 2024, an estimated $265K.
  • GTS Securities first reported a position in Teladoc Health in Q2 2023 and held it in 5 quarters.
  • GTS Securities's Teladoc Health position peaked at $2.47M in Q4 2023.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.